Defensins, lectins, mucins, and secretory immunoglobulin A: microbe-binding biomolecules that contribute to mucosal immunity in the human gut

Critical Reviews in Biochemistry and Molecular Biology

Volumn 52, Issue 1, 2017, Pages 45-56

  Chairatana, Phoom ^a   Nolan, Elizabeth M ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

defensins; host defense; lectins; mucins; Mucosal immunity; Paneth cells; sIgA

Indexed keywords

DEFENSIN; INTELECTIN; LECTIN; MUCIN; SECRETORY IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

CELL INVASION; HOST CELL; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INTESTINE EPITHELIUM; INTESTINE FLORA; INTESTINE MUCOSA; MUCOSAL IMMUNITY; PANETH CELL; PRIORITY JOURNAL; REVIEW; SECRETORY CELL; GASTROINTESTINAL TRACT; IMMUNOLOGY;

DEFENSINS; GASTROINTESTINAL TRACT; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A, SECRETORY; LECTINS; MUCINS; PANETH CELLS;

EID: 85009494276     PISSN: 10409238     EISSN: 15497798     Source Type: Journal    
DOI: 10.1080/10409238.2016.1243654     Document Type: Review

References (114)

1. Ambort D, Johansson MEV, Gustafsson JK, et al. (2012). Calcium and pH-dependent packing and release of the gel-forming MUC2 mucin. Proc Natl Acad Sci USA 109:5645–50.
2. Asker N, Axelsson MAB, Olofsson SO, Hansson GC., (1998). Dimerization of the human MUC2 mucin in the endoplasmic reticulum is followed by a N-glycosylation-dependent transfer of the mono- and dimers to the Golgi apparatus. J Biol Chem 273:18857–63.
3. Ayabe T, Satchell DP, Wilson CL, et al. (2000). Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 1:113–18.
4. Bergstrom KSB, Xia L., (2013). Mucin-type O-glycans and their roles in intestinal homeostasis. Glycobiology 23:1026–37.
5. Bevins CL, Salzman NH., (2011). Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol 9:356–68.
6. Broekaert WF, Terras FRG, Cammue BPA, Osborn RW., (1995). Plant defensins:novel antimicrobial peptides as components of the host defense system. Plant Physiol 108:1353–8.
7. Cash HL, Whitham CV, Behrendt CL, Hooper LV., (2006). Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313:1126–30.
8. Cerovic V, Bain CC, Mowat AM, Milling SWF., (2014). Intestinal macrophages and dendritic cells:what's the difference? Trends Immunol 35:270–7.
9. Chairatana P, Chu H, Castillo PA, et al. (2016). Proteolysis triggers self-assembly and unmasks innate immune function of a human α-defensin peptide. Chem Sci 7:1738–52.
10. Chairatana P, Nolan EM., (2014). Molecular basis for self-assembly of a human host-defense peptide that entraps bacterial pathogens. J Am Chem Soc 136:13267–76.
11. Cheng H., (1974a). Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. II. Mucous cells. Am J Anat 141:481–501.
12. Cheng H., (1974b). Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. IV. Paneth cells. Am J Anat 141:521–35.
13. Cheng H, Leblond CP., (1974a). Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. I. Columnar cell. Am J Anat 141:461–79.
14. Cheng H, Leblond CP., (1974b). Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. III. Entero-endocrine cells. Am J Anat 141:503–19.
15. Chileveru HR, Lim SA, Chairatana P, et al. (2015). Visualizing attack of Escherichia coli by the antimicrobial peptide human defensin 5. Biochemistry 54:1767–77.
16. Choi SM, McAleer J, Zheng M, et al. (2013). Innate Stat3-mediated induction of the antimicrobial protein Reg3γ is required for host defense against MRSA pneumonia. J Exp Med 210:551–61.
17. Christa L, Carnot F, Simon MT, et al. (1996). HIP/PAP is an adhesive protein expressed in hepatocarcinoma, normal Paneth, and pancreatic cells. Am J Physiol 271:G993–1002.
18. Chu H, Pazgier M, Jung G, et al. (2012). Human α-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. Science 337:477–81.
19. Clevers HC, Bevins CL., (2013). Paneth cells:maestros of the small intestinal crypts. Annu Rev Physiol 75:289–311.
20. Conibear AC, Rosengren KJ, Harvey PJ, Craik DJ., (2012). Structural characterization of the cyclic cystine ladder motif of θ-defensins. Biochemistry 51:9718–26.
21. Corfield AP., (2015). Mucins:a biologically relevant glycan barrier in mucosal protection. Biochim Biophys Acta 1850:236–52.
22. Costello EK, Lauber CL, Hamady M, et al. (2009). Bacterial community variation in human body habitats across space and time. Science 326:1694–7.
23. Cunliffe RN, Rose FRAJ, Keyte J, et al. (2001). Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease. Gut 48:176–85.
24. Destoumieux D, Bulet P, Loew D, et al. (1997). Penaeidins, a new family of antimicrobial peptides isolated from the shrimp Penaeus vannamei (decapoda). J Biol Chem 272:28398–406.
25. Dommett R, Zilbauer M, George JT, Bajaj-Elliott M., (2005). Innate immune defence in the human gastrointestinal tract. Mol Immunol 42:903–12.
26. Ericksen B, Wu Z, Lu W, Lehrer RI., (2005). Antibacterial activity and specificity of the six human α-defensins. Antimicrob Agents Chemother 49:269–75.
27. Evans EW, Beach GG, Wunderlich J, Harmon BG., (1994). Isolation of antimicrobial peptides from avian heterophils. J Leukoc Biol 56:661–5.
28. Forbes SJ, Bumpus T, McCarthy EA, et al. (2011). Transient suppression of Shigella flexneri type 3 secretion by a protective O-antigen-specific monoclonal IgA. mBio 2:e00042–11.
29. Furci L, Baldan R, Bianchini V, et al. (2015). New role for human α-defensin 5 in the fight against hypervirulent Clostridium difficile strains. Infect Immun 83:986–95.
30. Furness JB, Rivera LR, Cho HJ, et al. (2013). The gut as a sensory organ. Nat Rev Gastroenterol Hepatol 10:729–40.
31. Ganz T., (2003). Defensins:antimicrobial peptides of innate immunity. Nat Rev Immunol 3:710–20.
32. Ghoos Y, Vantrappen G., (1971). The cytochemical localization of lysozyme in Paneth cell granules. Histochem J 3:175–8.
33. Ghosh D, Porter E, Shen B, et al. (2002). Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol 3:583–90.
34. Godl K, Johansson MEV, Lidell ME, et al. (2002). The N terminus of the MUC2 mucin forms trimers that are held together within a trypsin-resistant core fragment. J Biol Chem 277:47248–56.
35. Harwig SSL, Swiderek KM, Kokryakov VN, et al. (1994). Gallinacins:cysteine-rich antimicrobial peptides of chicken leukocytes. FEBS Lett 342:281–5.
36. Hattrup CL, Gendler SJ., (2008). Structure and function of the cell surface (tethered) mucins. Annu Rev Physiol 70:431–57.
37. Hill CP, Yee J, Selsted ME, Eisenberg D., (1991). Crystal structure of defensin HNP-3, an amphiphilic dimer:mechanisms of membrane permeabilization. Science 251:1481–5.
38. Hooper LV, Littman DR, Macpherson AJ., (2012). Interactions between the microbiota and the immune system. Science 336:1268–73.
39. Hoover DM, Chertov O, Lubkowski J., (2001). The structure of human β-defensin-1:new insights into structural properties of β-defensins. J Biol Chem 276:39021–26.
40. Johansson MEV, Phillipson M, Petersson J, et al. (2008). The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A 105:15064–9.
41. Jonckheere N, Van Seuningen I., (2010). The membrane-bound mucins:from cell signalling to transcriptional regulation and expression in epithelial cancers. Biochimie 92:1–11.
42. Jones DE, Bevins CL., (1992). Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 267:23216–25.
43. Jones DE, Bevins CL., (1993). Defensin-6 mRNA in human Paneth cells:implications for antimicrobial peptides in host defense of the human bowel. FEBS Lett 315:187–92.
44. Kashyap PC, Marcobal A, Ursell LK, et al. (2013). Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiota. Proc Natl Acad Sci U S A 110:17059–64.
45. Kaur S, Kumar S, Momi N, et al. (2013). Mucins in pancreatic cancer and its microenvironment. Nat Rev Gastroenterol Hepatol 10:607–20.
46. Kavanaugh NL, Zhang AQ, Nobile CJ, et al. (2014). Mucins suppress virulence traits of Candida albicans. mBio 5:e01911–14.
47. Kim JJ, Khan WI., (2013). Goblet cells and mucins:role in innate defense in enteric infections. Pathogens 2:55–70.
48. 2 in human digestive organs. J Histochem Cytochem 40:1659–64.
49. Kudryashova E, Quintyn R, Seveau S, et al. (2014). Human defensins facilitate local unfolding of thermodynamically unstable regions of bacterial protein toxins. Immunity 41:709–21.
50. Lasserre C, Colnot C, Bréchot C, Poirier F., (1999). HIP/PAP gene, encoding a C-type lectin overexpressed in primary liver cancer, is expressed in nervous system as well as in intestine and pancreas of the postimplantation mouse embryo. Am J Pathol 154:1601–10.
51. Lehotzky RE, Partch CL, Mukherjee S, et al. (2010). Molecular basis for peptidoglycan recognition by a bactericidal lectin. Proc Natl Acad Sci U S A 107:7722–7.
52. Lehrer RI, Ganz T., (1999). Antimicrobial peptides in mammalian and insect host defence. Curr Opin Immunol 11:23–7.
53. Lehrer RI, Jung G, Ruchala P, et al. (2009). Multivalent binding of carbohydrates by the human alpha-defensin, HD5. J Immunol 183:480–90.
54. Lehrer RI, Lu W., (2012). α-Defensins in human innate immunity. Immunol. Rev 245:84–112.
55. Linden SK, Sutton P, Karlsson NG, et al. (2008). Mucins in the mucosal barrier to infection. Mucosal Immunol 1:183–97.
56. Lindner C, Wahl B, Föhse L, et al. (2012). Age, microbiota, and T cells shape diverse individual IgA repertoires in the intestine. J Exp Med 209:365–77.
57. Linzmeier R, Ho CH, Hoang BV, Ganz T., (1999). A 450-kb contig of defensin genes on human chromosome 8p23. Gene 233:205–11.
58. Litman GW, Rast JP, Fugmann SD., (2010). The origins of vertebrate adaptive immunity. Nat Rev Immunol 10:543–53.
59. Loonen LMP, Stolte EH, Jaklofsky MTJ, et al. (2014). REG3γ-deficient mice have altered mucus distribution and increased mucosal inflammatory responses to the microbiota and enteric pathogens in the ileum. Mucosal Immunol 7:939–47.
60. Macpherson AJ, Geuking MB, McCoy KD., (2012). Homeland security:IgA immunity at the frontiers of the body. Trends Immunol 33:160–7.
61. Mantis NJ, Rol N, Corthésy B., (2011). Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol 4:603–11.
62. McGuckin MA, Lindén SK, Sutton P, Florin TH., (2011). Mucin dynamics and enteric pathogens. Nat Rev Microbiol 9:265–78.
63. Moser S, Chileveru HR, Tomaras J, Nolan EM., (2014). A bacterial mutant library as a tool to study the attack of a defensin peptide. ChemBioChem 15:2684–8.
64. Mukherjee S, Zheng H, Derebe MG, et al. (2014). Antibacterial membrane attack by a pore-forming intestinal C-type lectin. Nature 505:103–7.
65. Ouellette AJ, Darmoul D, Tran D, et al. (1999). Peptide localization and gene structure of cryptdin 4, a differentially expressed mouse Paneth cell α-defensin. Infect Immun 67:6643–51.
66. Pabst O, Cerovic V, Hornef M., (2016). Secretory IgA in the coordination of establishment and maintenance of the microbiota. Trends Immunol 37:287–96.
67. Parkin J, Cohen B., (2001). An overview of the immune system. Lancet 357:1777–89.
68. Pazgier M, Wei G, Ericksen B, et al. (2012). Sometimes it takes two to tango:contributions of dimerization to functions of human α-defensin HNP1 peptide. J Biol Chem 287:8944–53.
69. Perez-Vilar J, Mabolo R, Mcvaugh CT, et al. (2006). Mucin granule intraluminal organization in living mucous/goblet cells:roles of protein post-translational modifications and secretion. J Biol Chem 281:4844–55.
70. Perlroth J, Choi B, Spellberg B., (2007). Nosocomial fungal infections:epidemiology, diagnosis, and treatment. Med Mycol 45:321–46.
71. Peterson LW, Artis D., (2014). Intestinal epithelial cells:regulators of barrier function and immune homeostasis. Nat Rev Immunol 14:141–53.
72. Png CW, Lindén SK, Gilshenan KS, et al. (2010). Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 105:2420–8.
73. Porter EM, Bevins CL, Ghosh D, Ganz T., (2002). The multifaceted Paneth cell. Cell Mol Life Sci 59:156–70.
74. Porter EM, Liu L, Oren A, et al. (1997a). Localization of human intestinal defensin 5 in Paneth cell granules. Infect Immun 65:2389–95.
75. Porter EM, van Dam E, Valore EV, Ganz T., (1997b). Broad-spectrum antimicrobial activity of human intestinal defensin 5. Infect Immun 65:2396–401.
76. Qin J, Li R, Raes J, et al. (2010). A human gut microbial gene catalog established by metagenomic sequencing. Nature 464:59–65.
77. Quayle AJ, Porter EM, Nussbaum AA, et al. (1998). Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol 152:1247–58.
78. Rajabi M, Ericksen B, Wu X, et al. (2012). Functional determinants of human enteric α-defensin HD5:a crucial role for hydrophobicity at dimer interface. J Biol Chem 287:21615–27.
79. Robinson JK, Blanchard TG, Levine AD, et al. (2001). A mucosal IgA-mediated excretory immune system in vivo. J Immunol 166:3688–92.
80. Salzman NH, Ghosh D, Huttner KM, et al. (2003). Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 442:522–6.
81. Salzman NH, Hung K, Haribhai D, et al. (2010). Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 11:76–83.
82. Sansonetti PJ., (2011). To be or not to be a pathogen:that is the mucosally relevant question. Mucosal Immunol 4:8–14.
83. Santaolalla R, Fukata M, Abreu MT., (2011). Innate immunity in the small intestine. Curr Opin Gastroenterol 27:125–31.
84. Sardi JCO, Scorzoni L, Bernardi T, et al. (2013). Candida species:current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol 62:10–24.
85. Satoh Y, Habara Y, Ono K, Kanno T., (1995). Carbamylcholine-and catecholamine-induced intracellular calcium dynamics of epithelial cells in mouse ileal crypts. Gastroenterology 108:1345–56.
86. Snoeck V, Goddeeris B, Cox E., (2005). The role of enterocytes in the intestinal barrier function and antigen uptake. Microbes Infect 7:997–1004.
87. Sommer F, Adam N, Johansson MEV, et al. (2014). Altered mucus glycosylation in core 1 O-glycan-deficient mice affects microbiota composition and intestinal architecture. PLoS One 9:e85254.
88. Sonnenburg JL, Xu J, Leip DD, et al. (2005). Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 307:1955–9.
89. Specian RD, Oliver MG., (1991). Functional biology of intestinal goblet cells. Am J Physiol 260:C183–93.
90. Spencer JD, Hains DS, Porter E, et al. (2012). Human alpha defensin 5 expression in the human kidney and urinary tract. PLoS One 7:e31712.
91. Stokes CR, Soothill JF, Turner MW., (1975). Immune exclusion is a function of IgA. Nature 255:745–6.
92. Szyk A, Wu Z, Tucker K, et al. (2006). Crystal structures of human α-defensins HNP4, HD5, and HD6. Protein Sci 15:2749–60.
93. Tang YQ, Yuan J, Ösapay G, et al. (1999). A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated α-defensins. Science 286:498–502.
94. Thomassin JL, Lee MJ, Brannon JR, et al. (2013). Both group 4 capsule and lipopolysaccharide O-antigen contribute to enteropathogenic Escherichia coli resistance to human α-defensin 5. PLoS One 8:e82475.
95. Thomsen T, Schlosser A, Holmskov U, Sorensen GL., (2011). Ficolins and FIBCD1:soluble and membrane bound pattern recognition molecules with acetyl group selectivity. Mol Immunol 48:369–81.
96. Thornton DJ, Rousseau K, McGuckin MA., (2008). Structure and function of the polymeric mucins in airways mucus. Annu Rev Physiol 70:459–86.
97. Trabi M, Schirra HJ, Craik DJ., (2001). Three-dimensional structure of RTD-1, a cyclic antimicrobial defensin from Rhesus macaque leukocytes. Biochemistry 40:4211–21.
98. Tsuji S, Uehori J, Matsumoto M, et al. (2001). Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall. J Biol Chem 276:23456–63.
99. Vaerman JP, Derijck-Langendries A, Rits M, Delacroix D., (1985). Neutralization of cholera toxin by rat bile secretory IgA antibodies. Immunology 54:601–3.
100. Verdugo P., (2012). Supramolecular dynamics of mucus. Cold Spring Harb Perspect Med 2:a009597.
101. Voehringer D, Stanley SA, Cox JS, et al. (2007). Nippostrongylus brasiliensis:identification of intelectin-1 and -2 as Stat6-dependent genes expressed in lung and intestine during infection. Exp Parasitol 116:458–66.
102. Wanniarachchi YA, Kaczmarek P, Wan A, Nolan EM., (2011). Human defensin 5 disulfide array mutants:disulfide bond deletion attenuates antibacterial activity against Staphylococcus aureus. Biochemistry 50:8005–17.
103. Wehkamp J, Chu H, Shen B, et al. (2006). Paneth cell antimicrobial peptides:topographical distribution and quantification in human gastrointestinal tissues. FEBS Lett 580:5344–50.
104. Wehkamp J, Stange EF., (2010). Paneth's disease. J Crohns Colitis 4:523–31.
105. Wei G, de Leeuw E, Pazgier M, et al. (2009). Through the looking glass, mechanistic insights from enantiomeric human defensins. J Biol Chem 284:29180–92.
106. Weis WI, Taylor ME, Drickamer K., (1998). The C-type lectin superfamily in the immune system. Immunol Rev 163:19–34.
107. Wesener DA, Wangkanont K, McBride R, et al. (2015). Recognition of microbial glycans by human intelectin-1. Nat Struct Mol Biol 22:603–10.
108. Wommack AJ, Robson SA, Wanniarachchi YA, et al. (2012). NMR solution structure and condition-dependent oligomerization of the antimicrobial peptide human defensin 5. Biochemistry 51:9624–37.
109. Wommack AJ, Ziarek JJ, Tomaras J, et al. (2014). Discovery and characterization of a disulfide-locked C(2)-symmetric defensin peptide. J Am Chem Soc 136:13494–7.
110. Woof JM, Russell MW., (2011). Structure and function relationships in IgA. Mucosal Immunol 4:590–7.
111. Zhao L, Ericksen B, Wu X, et al. (2012). Invariant Gly residue is important for α-defensin folding, dimerization, and function:a case study of the human neutrophil α-defensin HNP1. J Biol Chem 287:18900–12.
112. Zhao L, Lu W., (2014). Defensins in innate immunity. Curr Opin Hematol 21:37–42.
113. Zhu S., (2008). Discovery of six families of fungal defensin-like peptides provides insights into origin and evolution of the CSαβ defensins. Mol Immunol 45:828–38.
114. Zou J, Mercier C, Koussounadis A, Secombes C., (2007). Discovery of multiple beta-defensin like homologues in teleost fish. Mol Immunol 44:638–47.